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Mediawatch: There are expecta-
tions that new research on stem
cells may help resolve moral and
ethical issues, writes Richard F.
Harris.
Americans have great expectations
for science. They expect research to
solve practical problems such as
disease and slow internet
connections. But there’s a bemusing
expectation that research can also
resolve moral and ethical dilemmas.
Consider stem cells. 
Hardly a week goes by these days
without a flurry of reports about one
medical advance or another using
stem cells. Cures for diabetes,
Parkinson’s and Alzheimer’s are
perpetually just around the corner
(perhaps people haven’t realized that
the roadway is like the spiraling ramp
in a parking garage). Increasingly, the
hope and expectation seems to be
that stem cell research will also
resolve the queasiness many
Americans feel about using discarded
embryos as the source of that tissue.
Every time a scientist publishes
promising results using adult stem
cells (even those derived from
rodents), the chorus rises on Capitol
Hill that embryonic stem cells are all
but obsolete. 
Take for example Fred Gage’s
work in isolating stem cells from
human cadavers. USA Today said,
sure it could be used to regenerate
human organs someday. But it also
solves an immediate problem: “The
report suggests cadaver brains, if
retrieved quickly from deceased
infants, may offer a reasonable
alternative to embryos and fetuses as
sources of cells for
neurodegenerative diseases.” 
“We do not need to go to extreme
measures by making and destroying
carbon copies of people,’’ said actress
Margaret Colin, in an Associated Press
dispatch. “She and other abortion
opponents told senators that a
different type of stem cell can be
obtained from adult tissue.” 
But researchers take pains at every
step to point out that they haven’t
crossed that Rubicon. In a widely
quoted editorial in Science, Caltech
President David Baltimore and Irving
Weissman at Stanford noted that
“The wrong action here could close
the door to an important avenue of
scientific and clinical discovery.” The
Boston Globe noted: “Stem cells found
in organs in adult humans are less
controversial but also less understood.
While some have been shown capable
of turning into other cell types —
bone marrow into heart cells, for
example — they seem to be much
more limited in their repertoire.” 
In its story about cells derived
from cadavers, the Chicago Tribune
risked sounding a bit didactic to spell
out exactly what had — and
hadn’t — been ascertained in the
cadaver study. “Fred Gage of the
Salk Institute for Biological Studies
in La Jolla, California, said he is
worried that the public has become
so inundated by stories about
embryonic stem cells, adult stem
cells, cloning and the like, that the
science that underlies the ethical
debate often gets short shrift. He is
trying to be very careful about what
his lab has done. ‘We haven’t proved
that these are stem cells,’ he
cautioned. ‘Nor have we shown the
cells will actually work; that they
could heal an injured brain if
transplanted.’” 
And it doesn’t help that some
stories have been over-interpreted
because they’re simply too ‘sexy’ —
that’s ‘appealing’ in news lingo — to
ignore. In particular, journalists went
to town on the story asserting that
despised fat deposits could actually be
gold mines for therapeutic stem cells.
The response was entirely
predictable. As the Los Angeles Times
reported, “When scientists this month
reported isolating stem cells in human
fat, the American Life League, an
anti-abortion group, said the finding
gave Bush another reason ‘to leave
behind the horrors of embryonic stem
cell experimentation, which always
involves the killing of human
persons.’” 
The Tulsa World, swayed by a
report in the Wall Street Journal,
concluded just the opposite. “Alas,
using those love handles to build
organs and life-saving tissues is too
good to be true. Like most things in
that category, it is unfortunately not
true. But the White House — in
playing to the anti-abortion crowd —
is pushing the fat cell story.” 
The Chicago Sun-Times also called
that argument a ‘red herring,’ and
noted, “just as Galileo’s studies of
the solar system evoked religious
condemnation, so too does the stem
cell research that advances the
prospect of preventing and treating
heart disease, diabetes, cancer, AIDS,
Parkinson’s disease, Alzheimer’s and
a host of other life-threatening
illnesses.” 
Even so, the Bush Administration
has held off on granting permission
for federally funded researchers to
conduct research on discarded
human embryos. That may play well
to the anti-abortion constituency, but
Fred Gage noted in an op-ed piece in
the San Diego Union-Tribune that it
merely submerges the issue rather
than resolving it. “While we await
action on approved guidelines from
the federal government, unregulated
research continues to be carried out
by private companies using private
funding… Oversight of federally
funded research would cover such
issues as the source of cells, informed
consent, and measures to ensure
safety and the ethical use of
embryonic stem cells.” 
Of course, that presumes the
government would act rationally. Bad
assumption. 
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